Pivotal Therapeutics is a specialty pharmaceutical company with a focus on cardiovascular disease and overall health. The company’s lead product VASCAZENTM is a prescription only Medical Food formulated to meet the dietary Omega-3 deficient needs of patients with cardiovascular disease … Continue reading →

Ohr Pharmaceutical is a pharmaceutical company focused on the clinical development of new drugs to address underserved therapeutic needs in markets that are large and growing. The company is currently focused on two lead compounds: Squalamine eye drops for treating … Continue reading →

TrovaGene is developing its patented technology for the detection of transrenal DNA and RNA, short nucleic acid fragments originating from normal, and diseased cell death. The company has U.S. and European patent applications and issued patents that cover testing for … Continue reading →

Gilat Satellite Networks, a provider of products and services for satellite-based broadband communications, develops and markets a wide range of high-performance satellite ground segment equipment and VSATs. The company enables mobile SOTM (Satellite-on-the-Move) solutions providing low-profile antennas, next generation solid-state … Continue reading →

Marlborough Software Development Holdings provides marketing solutions, Web-to-print solutions and document solutions. The company’s Pageflex brand enables companies across the globe to communicate their marketing messages using the patented Pageflex variable publishing engine and Adobe® InDesign®. Pageflex products enable brand … Continue reading →

Infinity Pharmaceuticals is an innovative drug discovery and development company focused on the discovery, development and delivery of medicines for diseases with significant unmet need. The company’s programs are focused on the inhibition of phosphoinositide-3-kinase, heat shock protein 90, and … Continue reading →

NovaBay Pharmaceuticals is a clinical-stage biotechnology company engaged in developing two distinct categories of product offerings to address the large, unmet therapeutic needs of the worldwide anti-infective market. The company’s first-in-class Aganocide compounds are patented synthetic molecules that mimic white … Continue reading →

Savient Pharmaceuticals is a specialty biopharmaceutical company specializing in the development and commercialization of KRYSTEXXA (pegloticase) for treating chronic gout in adult patients refractory to conventional therapy. The company has exclusively licensed global rights to the technology related to KRYSTEXXA … Continue reading →